Journal of asthma, allergy and clinical immunology (천식및알레르기)

The Korean Academy of Asthma, Allergy and Clinical Immunology (대한천식알레르기학회)
권호 표지

A Case of Codeine Induced Urticaria/Angioedema

코데인에 의해 유발된 두드러기 및 혈관부종 1예

Sung, Jun-Mo;Shin, Yoo-Seob;Kim, Moo-Jung;Lee, Yoon-Suk;Park, Han-Jung;Hur, Gyu-Young;Ye , Young-Min;Park, Hae-Sim;Choi, Gil-Soon
성준모;신유섭;김무정;이윤석;박한정;허규영;예영민;박해심;최길순

  • Published : 20080900
⟨ Previous Next ⟩

Abstract

A 26-year-old female patient had complained of generalized urticaria with perioral and periorbital angioedema within 30 minutes after taking 20 mg of codeine phosphate. She had suffered from allergic rhinitis sensitized to animal danders, tree and weed pollens. Skin prick test (SPT) and basophil histamine release test with codeine phosphate (0.1, 1 and 10 mg/mL) were done with cytochrome P4502D6 (CYP2D6) genotyping. The skin prick test showed that the wheal/ erythema size of codeine phosphate (10 mg/mL) and morphine (10 mg/mL) were 3×2/14×7 and 3×2/15×8 mm, when compared to that of histamine (4×3/22×19 mm). The results of CYP2D6 genotype revealed that she has CYP2D6*10B/ *10B allele which means decreased turnover to morphine. Histamine releasing ability in response to codeine phosphate were ennanced in a dose-dependent manner (11.47% in 0.1 mg/mL, 62.84% in 1 mg/mL and 91.74% in 10 mg/ mL, respectively), while minimal histamine release was shown in control basophils. To the best of our knowledge, this is the first case of codeine-induced urticaria/angioedema, which has been caused by direct histamine releasing effect of codeine itself in Korea. (Korean J Asthma Allergy Clin Immunol 2008;28:234-237)

Keywords

References

  1. Vree TB, Verwey-van Wissen CP. Pharmacokinetics and metabolism of codeine in humans. Biopharm Drug Dispos 1992;13: 445-60 https://doi.org/10.1002/bdd.2510130607
  2. Quiding H, Lundqvist G, Boreus LO, Bondesson U, Ohrvik J. Analgesic effect and plasma concentrations of codeine and morphine after two dose levels of codeine following oral surgery. Eur J Clin Pharmacol 1993;44:319-23 https://doi.org/10.1007/BF00316466
  3. Casale TB, Bowman S, Kaliner M. Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and nonopiate receptor participation. J Allergy Clin Immunol 1984;73:775-81 https://doi.org/10.1016/0091-6749(84)90447-0
  4. Arndt KA, Jick H. Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program. JAMA 1976;235:918-23 https://doi.org/10.1001/jama.235.9.918
  5. Schoenfeld MR. Acute allergic reactions to morphine, codeine, meperidine, hydrocholoride, and opium alkaloid. N Y State J Med 1960;60:2591-3
  6. De Groot AC, Conemans J. Allergic urticarial rash from oral codeine. Contact Dermatitis 1986;14:209-14 https://doi.org/10.1111/j.1600-0536.1986.tb01226.x
  7. Rodríguez A, Barranco R, Latasa M, de Urbina JJ, Estrada JL. Generalized dermatitis due to codeine. Cross-sensitization among opium alkaloids. Contact Dermatitis 2005;53:240 https://doi.org/10.1111/j.0105-1873.2005.0670h.x
  8. Vidal C, Pérez-Leiros P, Bugarín R, Armisén M. Fever and urticaria to codeine. Allergy 2000;55:416-7 https://doi.org/10.1034/j.1398-9995.2000.00556.x
  9. Harle DG, Baldo BA, Coroneos NJ, Fisher MM. Anaphylaxis following administration of papaveretum. Case report: implication of IgE antibodies that react with morphine and codeine, and identification of an allergenic determinant. Anesthesiology 1989; 71:489-94
  10. Kuokkanen K. Erythema fixum of the genitals and the mucous membranes. Int J Dermatol 1974;13:4-8 https://doi.org/10.1111/j.1365-4362.1974.tb01758.x
  11. Torok H. Dermatitis medicamentosa: a ten-year study. Dermatol Int 1969;8:57-62 https://doi.org/10.1111/j.1365-4362.1969.tb05332.x
  12. Ponte CD. A suspected case of codeine-induced erythema multiforme. Drug Intell Clin Pharm 1983;17:128-30 https://doi.org/10.1177/106002808301700210
  13. Hunskaar S, Dragsund S. Scarlatiniform rash and urticaria due to codeine. Ann Allergy 1985;54:240-1
  14. Rodriguez F, Fernandez L, Garcia-Abujeta JL, Maquiera E, Llaca HF, Jerez J. Generalized dermatitis due to codeine. Contact Dermatitis 1995;32:120
  15. Nasser SM, Ewan PW. Opiate-sensitivity: clinical characteristics and the role of skin prick testing. Clin Exp Allergy 2001;31: 1014-20 https://doi.org/10.1046/j.1365-2222.2001.01090.x
  16. Kubota T, Yamaura Y, Ohkawa N, Hara H, Chiba K. Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes. Br J Clin Pharmacol 2000;50:31-4 https://doi.org/10.1046/j.1365-2125.2000.00209.x
  17. Droll K, Bruce-Mensah K, Otton SV, Gaedigk A, Sellers EM, Tyndale RF. Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians. Pharmacogenetics 1998;8:325-33 https://doi.org/10.1097/00008571-199808000-00006
  18. Yu A, Kneller BM, Rettie AE, Haining RL. Expression, purification, biochemical characterization, and comparative function of human cytochrome P450 2D6.1, 2D6.2, 2D6.10, and 2D6.17 allelic isoforms. J Pharmacol Exp Ther 2002;303:1291-300 https://doi.org/10.1124/jpet.102.039891